Nature Communications (Jun 2024)
Obesity-associated microbiomes instigate visceral adipose tissue inflammation by recruitment of distinct neutrophils
- Dharti Shantaram,
- Rebecca Hoyd,
- Alecia M. Blaszczak,
- Linda Antwi,
- Anahita Jalilvand,
- Valerie P. Wright,
- Joey Liu,
- Alan J. Smith,
- David Bradley,
- William Lafuse,
- YunZhou Liu,
- Nyelia F. Williams,
- Owen Snyder,
- Caroline Wheeler,
- Bradley Needleman,
- Stacy Brethauer,
- Sabrena Noria,
- David Renton,
- Kyle A. Perry,
- Prabha Nagareddy,
- Daniel Wozniak,
- Sahil Mahajan,
- Pranav S. J. B. Rana,
- Maciej Pietrzak,
- Larry S. Schlesinger,
- Daniel J. Spakowicz,
- Willa A. Hsueh
Affiliations
- Dharti Shantaram
- Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center at The Ohio State University
- Rebecca Hoyd
- Pelotonia Institute for Immuno-Oncology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Alecia M. Blaszczak
- Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center at The Ohio State University
- Linda Antwi
- Pelotonia Institute for Immuno-Oncology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Anahita Jalilvand
- Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center at The Ohio State University
- Valerie P. Wright
- Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center at The Ohio State University
- Joey Liu
- Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center at The Ohio State University
- Alan J. Smith
- Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center at The Ohio State University
- David Bradley
- Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center at The Ohio State University
- William Lafuse
- Department of Microbial Infection and Immunity, The Ohio State University
- YunZhou Liu
- Pelotonia Institute for Immuno-Oncology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Nyelia F. Williams
- Pelotonia Institute for Immuno-Oncology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Owen Snyder
- Pelotonia Institute for Immuno-Oncology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Caroline Wheeler
- Pelotonia Institute for Immuno-Oncology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Bradley Needleman
- Center for Minimally Invasive Surgery, Department of General Surgery, The Ohio State University
- Stacy Brethauer
- Center for Minimally Invasive Surgery, Department of General Surgery, The Ohio State University
- Sabrena Noria
- Center for Minimally Invasive Surgery, Department of General Surgery, The Ohio State University
- David Renton
- Center for Minimally Invasive Surgery, Department of General Surgery, The Ohio State University
- Kyle A. Perry
- Center for Minimally Invasive Surgery, Department of General Surgery, The Ohio State University
- Prabha Nagareddy
- Department of Internal Medicine, Cardiovascular Section University of Oklahoma Health Sciences Center (OUHSC)
- Daniel Wozniak
- Department of Microbial Infection and Immunity, The Ohio State University
- Sahil Mahajan
- Department of Microbial Infection and Immunity, The Ohio State University
- Pranav S. J. B. Rana
- Department of Microbial Infection and Immunity, The Ohio State University
- Maciej Pietrzak
- Department of Biomedical Informatics, The Ohio State University
- Larry S. Schlesinger
- Host Pathogen Interactions Program, Texas Biomedical Research Institute
- Daniel J. Spakowicz
- Pelotonia Institute for Immuno-Oncology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Willa A. Hsueh
- Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center at The Ohio State University
- DOI
- https://doi.org/10.1038/s41467-024-48935-5
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 18
Abstract
Abstract Neutrophils are increasingly implicated in chronic inflammation and metabolic disorders. Here, we show that visceral adipose tissue (VAT) from individuals with obesity contains more neutrophils than in those without obesity and is associated with a distinct bacterial community. Exploring the mechanism, we gavaged microbiome-depleted mice with stool from patients with and without obesity during high-fat or normal diet administration. Only mice receiving high-fat diet and stool from subjects with obesity show enrichment of VAT neutrophils, suggesting donor microbiome and recipient diet determine VAT neutrophilia. A rise in pro-inflammatory CD4+ Th1 cells and a drop in immunoregulatory T cells in VAT only follows if there is a transient spike in neutrophils. Human VAT neutrophils exhibit a distinct gene expression pattern that is found in different human tissues, including tumors. VAT neutrophils and bacteria may be a novel therapeutic target for treating inflammatory-driven complications of obesity, including insulin resistance and colon cancer.